Onradivir

CAS 2200336-20-3 · Antiviral, influenza PB2 inhibitor

Signals from filings dated June 2026 – June 2026 · Last checked 16 Nov 2026

Supply outlook

↑ GROWING

In the filings we track: 1 plant adding this molecule, 0 exit signals, 0 intermediate projects.

↑ Coming in1 plant+10 t/yr, where filed in tonnes
↓ Leaving0no drops or surrenders found
⇄ Own intermediates0no KSM projects found
Furthest stageEIA approvedapproval is not production

Signals

Hangzhou Bay Shangyu Economic and Technological Development Zone, Shaoxing, Zhejiang

  1. ✓ EIA filed
  2. ✓ Approval notice
  3. ✓ EIA approved · 18 Jun 2026
  4. Next: completion check
  5. DMF / CEP

Part of a 734 t/yr upgrade of existing workshops 3, 11, 12 and 15 (20 APIs). Approval No. Shao Shi Huan Shen [2026] No. 32, 18 Jun 2026. The document does not say whether the product is already made at the site. Source: Shaoxing Ecology and Environment Bureau, pre-approval notice

Why capacity is shown as filed →

Who makes Onradivir today

Current manufacturers with US DMF and CEP status, plant addresses and contacts, in the api-fdf.com database.

See all manufacturers →
ManufacturerCountryUS DMFCEPContact
Locked · in database
Locked · in database
Locked · in database

Names, plant addresses and contacts are shown in the database.

Follow Onradivir

Get an email when a new filing adds, cuts or moves this molecule to the next stage.

Follow

Other molecules with signals